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ABSTRACT 
Technology Transfer is fundamental and crucial to the drug development process for new drug products. The great decision is based on that factor 
in which the concept or process is advanced from research and development-oriented scheme to aimed towards the commercialization of the drug. 
The transfer could also be said to achieve success if the receiving section and the transferee can efficiently use the technology for profit. The 
achievement relies upon an understanding of the process or the capability to predict exactly the future prospects of a process. The main intention of 
this review article is to study the Regulatory aspects of technology transfer. This review article is mainly focused on the Consequence of technology 
transfer, the purpose for technology transfer in industries, barriers concerned with technology transfer, classification regarding technology transfer, 
facets of technology transfer, and steps among technology transferThis review was carried out by systematic searches of data integrity in relevant 
ICH, WHO, and US guidelines, published articles, reviews and abstracts in Google scholar, Pubmed, Science direct, Embase, Web of science of articles 
up to 2020.  
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INTRODUCTION 
The terminology “Technology Transfer is the manner of interchange 
of technology and the invention from one area to a different area [1]. 
Across the pharmaceutical industry technology transfer states that 
the processes related to the fortunate movement of drug discovery 
to development and finally full-size promotion [2]. 
The consequence of technology transfer in the pharmaceutical 
industry  
• For the Transfer of technology from R and D to manufacturing 
site clear information is mandatory. 
• To accentuate information on the transfer technology of already 
available products among various manufacturing areas.  
• This is required to enlighten particular procedures for 
technology transfer and contribute to continuous technology 
transfer. 
• To establish an association between research institutes and 
profitable organizations [3]. 
Purpose of technology transfer  
1. Inadequacy of manufacturing extent: The technology introducer 
might have its own manufacturing equipment that is applicable to small 
scale operation and large-scale manufacturing operations. 
2. Shortage of resources to discharge product commercially: 
For conducting the early stage analysis like animal studies and 
toxicology studies the inventor must-have resources. But for 
performing clinical studies the resources are not available. 
3. Deficiency of distribution and marketing competence: The 
inventor would completely establish a technology and obtained 
product registrations and regulatory approvals. 
4. Application in various fields: To create an extra income the 
inventor may transfer the technology to someone else to use in 
another field that varies from the already applied field [4, 5]. 
Obstacles of technology transfer  
The Obstacles confronted in technology transfer as follows:- 
• Lack of a persistent framework for the understanding of the 
technology concept. 
• Absence of procedures for receiving technology transfer in 
developing countries. 
• In the progress of technology transfer, there is a lack of bilateral 
benefits. 
• Unavailability of the persistent framework for analysis and 
evaluation of technology. 
• Ergonomic aspects are failed to integrate into technology 
transfer. 
• Lack of scrutiny to environmental and assessment of 
technological consequences.  
• The feasibility study of technology transfer is limiting money 
evaluation. 
• Misjudgment of the concept of technology usefulness.  
• In the technology transfer process presence of ethical issues [6, 7]. 
Goals of technology transfer  
• Technology transfer is an advantageous step in the development 
cycle to the commercial production of drug products. 
• All the collected information is used as the grounds for the 
process qualification and continuous improvement of the product 
and manufacturing control strategy. 
• The change of the data like the process, analytical data, or 
product between development and manufacturing plant. 
• Various parameters and processes are controlled to justify the 
accepted parameters throughout the development [8, 9]. 
Technology transfer is classified into two types by Mansfield they are:  
Classification of technology transfer 
1. Vertical transfer begins with 
2. 
preliminary research ending with 
clinical research to the manufacturing of new drug products. 
Horizontal transfer
According to Sounder’s (1990) classification, vertical technology 
transfer is the progress of moving technology from one phase to 
 means the development and the 
application of technology utilized in one area, context, or institution 
to a different area, context, or institution [10]. 
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another phase. vertical technology transfer is otherwise called 
internal technology transfer. Horizontal technology transfer is 
possible to transfer of technology at any stage of the lifecycle. 
Horizontal technology transfer is otherwise called external 
technology transfer [11]. 
Steenhuis (2002) categorized technology transfer into 
• 
Material 
transfer, Capacity transfer, and Design transfer. 





Various types of instructions or guidelines are transferred to 
meet the numerous requirements of the product is called a Capacity 
transfer. 
For improving the manufacturing of the product various designs 
and blueprints are transferred this is denoted as 
Steps in technology transfer  
design transfer [12]. 
Technology transfer is defined as the procedure for the transfer of 
information and technology fundamental to the production of drug 
products. The development of a new drug undergoes many stages. The 
transformation of a pharmaceutical prototype towards a profitable 
product required the participation of a variety of individuals. 
Appropriate care should be taken to assure the quality of the product. 
During the early phase development, various parameters are considered 
such as critical and non-critical parameters, excipient availability, 
equipment, and production environment. There are numerous steps that 
encompass technology transfer. Technology transfer flow in 
pharmaceutical industry is in fig. 1 [13]. All methods for testing a given 
product, ingredient, or cleaning sample should be provided. If it is 
deemed unnecessary to qualify the method in the Receiving Unit, the 
justification should be documented. Table 1 describes the various types 
of tests like assay, sterility, dissolution is transferred from technology 
receiving site for different types of formulations. 
 
Fig. 1: Technology transfer  flow in the pharmaceutical industry [15]
 
Table 1: API and dosage form tests to be transferred 
Tests API Dosage form 
Solid doses Parenterals Inhalation Semi-solids Suspensions Transdermal 
Assay X X X X X X X 
Content Uniformity  X X X X X X 
Impurities X X X X X X X 
Dissolution  X    X  
Identification X X X X X X X 
Cleaning Verification X X X X X X X 
Cleaning Verification X X X X X X X 
Dose Delivery    X    
Sterility   X    X 
 
1. Development of technology by research and development  
a. Design of procedure and choosing of excipients by research 
and development 
The R and D department is responsible for selecting materials and 
design procedures for the development of the drug. 
b. Determination of Specification and Quality by R and D 
The quality of the drug product must conform to the specifications of an 
innovator product that should be examined by the R and D Department. 
For manufacturing product and innovator products, various stability 
studies are performed to confirm the specifications [16]
2. Technology transfer from randd to production  
. 
The R and D department is implemented the Technology transfer 
dossier that contains all the detailed information about the 
formulation and the drug product includes:  
Master formula card 
MFC comprises a drug product name together with its MFC number, 
effective date, the strength of the formulation, generic name of the 
drug product, page number, and shelf life of the product [17]. 
Master packaging card 
Master Packaging Card is consisting of information regarding the 
material used for packaging of the product, packaging type, shelf life 
of the packaging, and stability of the packaging.  
Master formula 
It describes the instructions for the manufacturing and formulation 
of the product. Manufacturing instructions provide the objective of 
environmental conditions and dosage form development. 
Specifications and standard test procedure 
It is used to know about the active ingredients and excipients profile 
of the product, specification, in-process parameters, and finished 
product information [18]. 
3. Production phase (Optimization and production) 
a. Validation studies  
After conducting numerous validation studies production is started 
based on the manufacturing formula. The R and D department is 
responsible for the validation like process validation, cleaning 
validation, and performance qualification.  
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b. Scale-up for production  
This deals with the transferring of technology across the 
development of the processes and drug products. During the 
development of the process, it is necessary to investigate the 
production environment. Various operations are performed during 
the formulation of the solid dosage form. Technology transfer is 
implemented before the production begins [19]. 
c. Considerations of different parameters for scale-up  
Different parameters like innovation, flexibility, cost, product quality 
is considered for successful technology transfer. Good 
communication is an important factor for successful formulation and 
process transfer. 
d. Selection of method 
Based on the data from R and D the method for batch fabrication 
was chosen. The critical steps in technology transfer are granulation, 
blending, compression, and coating [20]. 
4. Technology transfer documentation 
The Document includes details of technology transfer towards 
transferred parties and transferring. From Research and 
Development to production every step must be documented, and all 
commitments ought to be rectified. The Quality Assurance 
department is responsible for the approval of documentation for 
technology transfer.  
A. Development report  
The R and D department is responsible for documentation. The 
Development Report is clarifying the quality design for drug 
substances, specifications, and test methods. For approval, this 
report is not necessary. The Development Report encompasses:  
(1) Data from the initial development stage to the final approval. 
(2) Raw materials and components information.  
(3) Manufacturing methods design. 
(4) Changes are made in the vital processes and parameters.  
(5) Specifications and test strategies for drug substances.  
(6) The validity of the specification range for the dissolution test 
and contents impurity.  
(7) Reports are checked [21] 
B. Technology transfer plan  
A technology transfer plan consists of complete procedures for 
individual transfer of technology, details regarding technology to be 
transferred, agenda for technology transfer, and decision criteria for 
technology transfer. Before the implementation of the transfer, the 
transferring party must prepare the plan. 
C. Report 
If the data is taken into the technology transfer plan only the 
technology transfer is completed. The data are assessed to 
confirm that the agreed criteria are met. Both transferred 
parties and transferring parties must document the report 
[22]. 
Factors affecting technology transfer  
7 factors are challenging towards establishing prerequisites for 
pharmaceutical technology transfers.  
(1) A feasible and reachable market 
(2) Suitable capital markets 
(3) Quality of the relationship between industry and the 
government 
(4) Appreciable economic governance, stability 
(5) Accessibility of skilled employee 
(6) Adequate regulation 
(7) Understandable development precedence [23] 
Facets of technology transfer  
The transfer of technology has occurred especially in the subsequent 
ways:  
A. Government laboratory to private sector firms 
B. Between private sector firms of the same country 
C. From academia to private sector firms  
D. Academia, government, and industry collaborations  
A. Govt. laboratory to private firms 
The Government labs will receive financial assistance and funds 
from the government for the conducting of research work and 
technology passes the private firms. So, this type is more 
advantageous. 
B. Among private firms of the same country  
Due to a lack of financial resources or insufficient information this 
type of technology transfer is takes place. The private firm 
establishes the technology is compensated by different firms. 
C. From academics to private firms 
The academic firm develops specific technology and is accessible to 
various private sectors. By the cooperation of private sectors with 
organizations, money is often saved. 
D. Among academy, govt. and private firms  
The government furnishes funds to the academic organizations 
for promoting technology this will be transmitted to the industry 
[24]. 
Who guidelines on transfer of technology 
Throughout the life cycle of the majority of medicines like the 
development of drug products, production, and launching into the 
market in all phases the processes are transferred to an alternate 
site. 
This WHO guideline will be applicable to both manufacturing of 
active pharmaceutical ingredients, production, and packaging of 
finished pharmaceutical products, and carrying out analytical testing 
[25]. 
Transfer of technology needs a plan and documentation utilizing 
the qualified and well-experienced person functioning in the 
quality system, with evidence of data regarding all areas of 
development, manufacturing, and quality control. Generally, 
there’s the unit managed the process, a receiving unit, and a 
sending unit [26]. Fig. 2 describes the WHO Guidelines on 
technology transfer. 
The WHO guidelines address the following areas at the 
receiving unit (RU) and sending unit (SU) 
• Transfer of development processes and Manufacturing of the 
drug product, packaging, and cleaning. 
• Transfer of methods of analysis for quality control, and quality 
assurance. 
• Competencies evaluation and training. 
• Evaluation of premises and equipment.  
• Documentation of all the data. 
• Organization and control of the technology transfer. 
Qualification and validation of all the processes [27]. 
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Fig. 2: WHO guidelines on technology transfer 
 
Transfer protocol 
The technology transfer protocol must list the intentional 




• Key personnel and their duties.  
• A parallel assessment of materials, processes, and equipment. 
• The technology transfer steps with documented proof that every 
single crucial step had been sufficiently accomplished earlier than 
the subsequent commences.  
• Identity of important control measures. 
• For analytical methods design and acceptance criteria 
• Details on the pilot batches, qualification batches, and process 
validation. 
• Change control procedure for any process discrepancies 
confronted. 
• Evaluation of the end-product  
• Provisions for retaining samples of active ingredients, 
intermediates, and finished drug products, and details on reference 
samples where appropriate. 
• Conclusion includes signed-off approval by the project manager [28]. 
Role of ich guidelines in technology transfer 
Technology transfer comprises of knowledge transfer, science, and 
risk-based principles inclusive of ICH Q8, Q9, Q10, Q11, and 
proficient processes to satisfy evolving commercial needs. The role 
of various ICH guidelines is providing in fig. 3. 
 
 
Fig. 3: Role of ICH guidelines 
 
This determines the requirements for profitable Technology 
Transfer and offers guidance for the conduct of technology transfer, 
which might be separately tailored, relying on the sort and scope of 
the transfer [29]. 
ICH Q10 guidelines on technology transfers 
According to ICH Q10 guidelines, “The intention of technology 
transfer operations is to transfer process, and product information 
among the development and manufacturing sites, and within 
production sites to attain product realization. This information is the 
basis for the manufacturing of the product, monitoring strategies, 
process validation, and ongoing persistent improvement.” 
To guarantee a successful technology transfer, pharmaceutical 
companies ought to create a collaborative improvement team must 
have the required qualification, knowledge, and skills to affect the 
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transfer, originate a written controlling method to concentrate 
attention on crucial points in the process and equipment, review the 
process for inputs/outputs that might affect the quality of the 
product [30]. 
FDA technology portfolio 
FDA's Technology Transfer assists the transfer of these technologies to 
the private firms via licensing and patenting of these developments. 
Therefore, new medicinal products like vaccines, counterfeit drug 
detection, manufacturing, and food pathogen detection systems
Over the past few years alone, FDA researchers are developed and 
reported around 20 patentable inventions every year. FDA retains 
over six hundred invention assets that exemplify over 100 unique 
technologies [31]. Article 101 of the Treaty on the Functioning of the 
EU to technology transfer agreements. Technology transfer 
agreements relate to the licensing of technology rights in which the 
licensor allows the licensee to create the licensed technology rights 
for the manufacturing of goods or products. The requirements set 
out in these guidelines should be utilized in the light of the 
conditions particular to every case. These guidelines do not include 
mechanical application. Every case needs to be evaluated on its own 
circumstances and these guidelines are applied flexibly, and 
reasonably [32]. 
 are 
developed and make accessible on the market. 
CONCLUSION 
Transfer of information and technologies are necessary to meet the 
quality of the drug during production. Technology transfer might be 
investigated fortunately in case a receiving section can constantly 
reproduce the process. The three fundamental points to be 
discussed throughout the technology transfer are the plan, the 
persons concerned, and the production process. Technology 
Transfer offers a possibility to decrease the cost of drug discovery 
and development thus pharmaceutical enterprises seek technology 
transfer opportunities as it rates of failure, reduce risk, and costs. A 
collaborative work by the technology team leads to better outcomes 
initial and consistent runs resulting in the prior license, earliest 
launch, and an increased market share. 
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